Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Israel Honors Pfizer CEO Albert Bourla with the "Jewish Nobel" Prize


News provided by

The Genesis Prize Foundation

29 Jun, 2022, 22:22 GMT

Share this article

Share toX

Share this article

Share toX

Bourla donates his $1 million Genesis Prize award towards the construction of the Holocaust Museum of Greece in Thessaloniki, to commemorate Greek-Jewish communities wiped out by the Nazis

JERUSALEM, June 29, 2022 /PRNewswire/ -- Today the President of Israel Isaac Herzog presented the Genesis Prize to Dr. Albert Bourla at a ceremony in Israel's capital Jerusalem.

The gala event brought together hundreds of dignitaries from Israel, including government ministers, heads of business and philanthropic organizations, as well as prominent representatives of the Jewish Diaspora and leading members of the global medical community.

Continue Reading
This image opens in the lightbox
President of Israel Isaac Herzog, Founder and Chairman of The Genesis Prize Foundation Stan Polovets, and 2022 Genesis Prize Laureate, Dr. Albert Bourla. Photography credit: Lior Mizrahi, Getty

The annual $1 million Genesis Prize, dubbed the "Jewish Nobel" by TIME magazine, honors extraordinary individuals for their outstanding professional achievement, contribution to humanity, commitment to Jewish values and the State of Israel.

Dr. Albert Bourla was announced as the 9th Genesis Prize Laureate in January 2022. The award recognizes his leadership in delivering a vaccine against COVID-19, which saved millions of lives during the pandemic. The Genesis Prize also celebrates the boldness of his vision and willingness to assume risks, which enabled delivery of the vaccine in record time.

In addition to honoring the vast humanitarian impact of Dr. Bourla's leadership, the award also celebrates his pride in his Jewish identity and heritage, and his strong support for the State of Israel.

The President of Israel Isaac Herzog said: "Albert Bourla was not deterred by high stakes, by naysayers, by conspiracy or by politics. He believed in the vaccine, and invested every ounce of himself in realizing what seemed at the time a far-fetched fantasy. The vaccine was developed in record speed, utilizing the technology of tomorrow to successfully hold back a devastating pandemic. A study published by The Lancet just days ago, points to nearly 20 million lives saved by COVID vaccines. Indeed, the vaccine gave us freedom we thought we lost. Albert, I congratulate you and your colleagues and counterparts, who are making such a critical impact on humanity, while embracing your Jewish heritage and values, and inspiring Jewish pride." Founder and Chairman of The Genesis Prize Foundation Stan Polovets added: "To save a human life is a fundamental Jewish value. Today we honor Dr. Bourla – a living embodiment of this ancient Jewish principle. We also celebrate the immense contribution of Jewish doctors who were on the frontline of the COVID pandemic for two years and who continue to save lives of people suffering in Ukraine today."

The ceremony opened with a moving tribute to the people of Ukraine and appreciation to the many Israeli and international Jewish organizations who are providing humanitarian aid. The Genesis Prize Foundation premiered a video "Jews in Medicine", exploring the roots and impact of Jews on the medical field from biblical times to the modern-day fight against the COVID pandemic (LINK TO VIDEO; for more details, please see section Jewish Contribution to Medicine).

2022 Genesis Prize Laureate Dr. Albert Bourla said: "I am honored and deeply humbled to receive the Genesis Prize. Honored because I never set out to be famous, and I never imagined that I would one day be up here with the illustrious nominees and past awardees—artists, philanthropists, and statesmen and stateswomen who show the world the best that the Jewish people have to offer. And humbled because this is not my award—it belongs to all Pfizer colleagues who worked tirelessly in the middle of a global pandemic to make the 'impossible possible' and give the world a chance to return to normalcy. Every life is precious and we must confront our challenges with courage, humility and perseverance. My Pfizer colleagues lived these values, and I am proud to be here in Israel to celebrate them and their extraordinary achievement."

Following the tradition established by the inaugural Genesis Prize Laureate Michael Bloomberg, Dr. Bourla announced that he will forgo the $1 million prize award and has asked the Foundation to donate the funds toward establishing the Holocaust Museum of Greece to be built in Thessaloniki.

Albert Bourla was born in Thessaloniki, home to an ancient Jewish community that traced its roots to antiquity. The vibrant Jewish community of 55,000 was almost completely wiped out during the Nazi occupation. Dr. Bourla's young parents narrowly escaped death and were among only 2,000 survivors. The Greek Holocaust Museum will immortalize the history of the Greek Jewish community from antiquity to modern age.

Photo - https://mma.prnewswire.com/media/1850725/The_Genesis_Prize_Foundation_President_Herzog_Stan_Polovets_Albert_Bourla.jpg

Modal title

Also from this source

Argentina's President Javier Milei Wins the 2025 "Jewish Nobel Prize"

Today, The Genesis Prize announces President of Argentina Javier Milei as the 2025 Genesis Prize Laureate, the first time the award, known as "The...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Religion

Religion

Awards

Awards

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.